Adjunctive interleukin-2 for the treatment of drug-susceptible tuberculosis: a randomized control trial in China.
Infection
; 50(2): 413-421, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-34562262
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tuberculosis
/
Tuberculosis, Pulmonary
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Infection
Year:
2022
Document type:
Article
Country of publication:
Alemania